Our study is the first analysis of the association between ERCC1 mRNA expression and treatment response in patients with cervical squamous cell carcinomas who received radical cisplatin-based concurrent chemoradiotherapy. The gene discussed is ERCC1; the disease is cervical squamous cell carcinoma.